EFM
E Fund Management Portfolio holdings
AUM
$2.1B
1-Year Return
23.31%
This Quarter Return
+21.94%
1 Year Return
+23.31%
3 Year Return
+155.42%
5 Year Return
–
10 Year Return
–
AUM
$1.2B
AUM Growth
+$128M
(+12%)
Cap. Flow
-$24.9M
Cap. Flow
% of AUM
-2.07%
Top 10 Holdings %
Top 10 Hldgs %
56.76%
Holding
362
New
28
Increased
88
Reduced
207
Closed
28
Top Buys
| 1 |
Tencent Music
TME
|
$41.7M |
| 2 |
Yum China
YUMC
|
$10.6M |
| 3 |
STAAR Surgical
STAA
|
$8.25M |
| 4 |
Sea Limited
SE
|
$7.13M |
| 5 |
Legend Biotech
LEGN
|
$5.83M |
Top Sells
| 1 |
NIO
NIO
|
$44.7M |
| 2 |
KE Holdings
BEKE
|
$22M |
| 3 |
Kanzhun
BZ
|
$10.1M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$10.1M |
| 5 |
Li Auto
LI
|
$8.53M |
Sector Composition
| 1 | Consumer Discretionary | 36.91% |
| 2 | Technology | 25.51% |
| 3 | Communication Services | 14.94% |
| 4 | Healthcare | 9.44% |
| 5 | Real Estate | 3.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Royal Caribbean
RCL
$95.7B
| $452K | 0.04% |
9,137
| – | – |
|
152
Bank of America
BAC
$369B
| $448K | 0.04% |
13,513
-514
| -4% | -$17K |
|
153
Alkermes
ALKS
$4.94B
| $447K | 0.04% |
17,116
-2,723
| -14% | -$71.1K |
|
|
ISEE
154
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $447K | 0.04% |
20,879
-4,745
| -19% | -$102K |
|
155
Apellis Pharmaceuticals
APLS
$3.55B
| $445K | 0.04% |
8,604
+1,554
| +22% | +$80.4K |
|
156
Natera
NTRA
$23.1B
| $445K | 0.04% |
11,083
+2,081
| +23% | +$83.6K |
|
157
Danaher
DHR
$143B
| $442K | 0.04% |
1,879
-122
| -6% | -$28.7K |
|
158
Amicus Therapeutics
FOLD
$2.46B
| $442K | 0.04% |
36,161
-5,551
| -13% | -$67.9K |
|
159
Ironwood Pharmaceuticals
IRWD
$188M
| $442K | 0.04% |
35,685
-7,619
| -18% | -$94.4K |
|
160
Xcel Energy
XEL
$43B
| $440K | 0.04% |
6,281
-260
| -4% | -$18.2K |
|
161
Prothena Corp
PRTA
$460M
| $436K | 0.04% |
7,243
-86
| -1% | -$5.18K |
|
162
Alnylam Pharmaceuticals
ALNY
$59.2B
| $434K | 0.04% |
1,828
-306
| -14% | -$72.7K |
|
|
SWTX
163
DELISTED
SpringWorks Therapeutics
SWTX
| $434K | 0.04% |
16,705
-98
| -0.6% | -$2.55K |
|
164
Motorola Solutions
MSI
$79.8B
| $433K | 0.04% |
1,682
| – | – |
|
165
Neurocrine Biosciences
NBIX
$14.3B
| $431K | 0.04% |
3,606
-867
| -19% | -$104K |
|
166
Exelixis
EXEL
$10.2B
| $430K | 0.04% |
26,803
+192
| +0.7% | +$3.08K |
|
167
BioMarin Pharmaceuticals
BMRN
$11.1B
| $428K | 0.04% |
4,131
-995
| -19% | -$103K |
|
168
Ionis Pharmaceuticals
IONS
$9.76B
| $426K | 0.04% |
11,272
+1,102
| +11% | +$41.6K |
|
169
Halozyme
HALO
$8.76B
| $423K | 0.04% |
7,427
-4,078
| -35% | -$232K |
|
170
PTC Therapeutics
PTCT
$4.55B
| $423K | 0.04% |
11,083
+2,202
| +25% | +$84K |
|
|
RXDX
171
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $422K | 0.04% |
3,836
-2,696
| -41% | -$297K |
|
|
KRTX
172
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $421K | 0.04% |
2,143
+229
| +12% | +$45K |
|
173
United Therapeutics
UTHR
$18.1B
| $419K | 0.03% |
1,508
-623
| -29% | -$173K |
|
174
Denali Therapeutics
DNLI
$2.26B
| $413K | 0.03% |
14,861
+607
| +4% | +$16.9K |
|
|
ANSS
175
DELISTED
Ansys
ANSS
| $411K | 0.03% |
1,702
-1
| -0.1% | -$241 |
|